Expression of nuclear receptor DAX-1 and androgen receptor in human breast cancer

Journal of Surgical Oncology

Volumn 103, Issue 8, 2011, Pages 768-772

  Chae, Byung Joo ^a   Lee, Ahwon ^b   Bae, Ja Seong ^a   Song, Byung Joo ^a   Jung, Sang Seol ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

androgen receptor; breast; DAX 1; immunohistochemistry; neoplasm

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; NUCLEAR RECEPTOR DAX 1; PROGESTERONE RECEPTOR;

ADULT; AGED; BREAST CANCER; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DAX-1 ORPHAN NUCLEAR RECEPTOR; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 79955703836     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21861     Document Type: Review

References (22)

1. Dowsett M, Dunbier AK:, Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer. Clin Cancer Res 2008; 14: 8019-8026.
2. Goldhirsch A, Glick JH, Gelber RD, et al.: Meeting highlights: International consensus panel on the treatment of primary breast cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001; 19: 3817-3827. (Pubitemid 32880060)
3. Ma W, Adjei A:, Novel agents on the horizon for cancer therapy. CA Cancer J Clin 2009; 59: 111-137.
4. Park S, Koo J, Park HS, et al.: Expression of androgen receptors in primary breast cancer. Ann Oncol 2010; 21: 488-492.
5. Moinfar F, Okcu M, Tsybrovskyy O, et al.: Androgen receptors frequently are expressed in breast carcinomas: Potential relevance to new therapeutic strategies. Cancer 2003; 98: 703-711. (Pubitemid 36959265)
6. Agrawal AK, Jelen M, Grzebieniak Z, et al.: Androgen receptors as a prognostic and predictive factor in breast cancer. Folia Histochem Cytobiol 2008; 46: 269-276.
7. Ogawa Y, Hai E, Matsumoto K, et al.: Androgen receptor expression in breast cancer: Relationship with clinicopathological factors and biomarkers. Int J Clin Oncol 2008; 13: 431-435.
8. Moe RE, Anderson BO:, Androgens and androgen receptors: A clinically neglected sector in breast cancer biology. J Surg Oncol 2007; 95: 437-439. (Pubitemid 46709384)
9. Ikeda Y, Swain A, Weber TJ, et al.: Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: Potential links in endocrine development. Mol Endocrinol 1996; 10: 1261-1272. (Pubitemid 26330958)
10. Lalli E, Sassone-Corsi P:, DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol Endocrinol 2003; 17: 1445-1453. (Pubitemid 36930462)
11. Holter E, Kotaja N, Mkela S, et al.: Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1. Mol Endocrinol 2002; 16: 515-528. (Pubitemid 34214571)
12. Mangelsdorf DJ, Thummel C, Beato M, et al.: The nuclear receptor superfamily: The second decade. Cell 1995; 83: 835-839.
13. Maglich JM, Sluder A, Guan X, et al.: Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes. Genome Biol 2001; 2: RESEARCH0029.
14. Crawford PA, Dorn C, Sadovsky Y, et al.: Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol Cell Biol 1998; 18: 2949-2956. (Pubitemid 28183464)
15. Ito M, Yu R, Jameson JL:, DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 1997; 17: 1476-1483. (Pubitemid 27097377)
16. Zhang H, Thomsen JS, Johansson L, et al.: DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem 2000; 275: 39855-39859. (Pubitemid 32065755)
17. Bae DS, Schaefer ML, Partan BW, et al.: Characterization of the mouse DAX-1 gene reveals evolutionary conservation of a unique amino-terminal motif and widespread expression in mouse tissue. Endocrinology 1996; 137: 3921-3927. (Pubitemid 26284667)
18. Muscatelli F, Strom TM, Walker AP, et al.: Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994; 372: 672-676.
19. Wang ZJ, Jeffs B, Ito M, et al.: Aromatase (Cyp19) expression is up-regulated by targeted disruption of Dax1. Proc Natl Acad Sci USA 2001; 98: 7988-7993. (Pubitemid 32642674)
20. Kuenen-Boumeester V, Van der Kwast TH, Claassen CC, et al.: The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters. Eur J Cancer 1996; 32A: 1560-1565. (Pubitemid 26279124)
21. Nahleh Z:, Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: An unchartered territory. Future Oncol 2008; 4: 15-21. (Pubitemid 351372603)
22. Rakha EA, El-Sayed ME, Green AR, et al.: Prognostic markers in triple-negative breast cancer. Cancer 2007; 109: 25-32. (Pubitemid 46120191)